Fresenius SE & Co. KGaA
Contact Person
Christoph Liesche
Company / Organization
1912
FoundersDr. Eduard Fresenius
OwnerFresenius SE & Co. KGaA
Revenue22,3 billion euros fiscal year 2023
Infusion therapy, generic medicines, biosimilars, clinical nutrition, transfusion technology, hospitals (Helios Kliniken Deutschland / Quirónsalud Kliniken Spain), projects and services for hospitals and other healthcare facilities, healthcare, health tourism
employees193.865 in more than 60 countries (2023)
Sales marketGlobal - Internationality is one of the strengths of the Fresenius Group. Fresenius Kabi, Fresenius Helios, and Fresenius Vamed operate successfully with their own subsidiaries in more than 60 countries.
Fresenius SE & Co. KGaA is a global healthcare company headquartered in Bad Homburg vd Höhe, Germany
As a therapy-focused healthcare company, Fresenius offers system-critical products and services for leading therapies for the care of critically and chronically ill patients.
Fresenius is listed on the German stock index DAX 40.
The Fresenius Group includes the operating segments Fresenius Kabi and Fresenius Helios as well as the subsidiaries Fresenius Medical Care and Fresenius Vamed.
With 145 hospitals and numerous outpatient facilities in Germany and Spain, Fresenius Helios is Europe's largest private hospital operator, caring for approximately 24 million patients annually. Fresenius Kabi offers medicines and medical technology for infusion, transfusion, and clinical nutrition worldwide and holds leading market positions.